Monthly Archives: January, 2013
Clinical Trial: Mesalazine for Irritable Bowel Syndrome with Diarrhea (IBS-D), United Kingdom
The Nottingham University Hospitals Trust, King’s Mill Hospital Mansfield, Derby Royal Hospital and Wythenshawe Hospital Manchester are looking for men and women age 18-75 with Rome III criteria diarrhea-predominant IBS to participate in a clinical trial of the medication mesalazine for the treatment of IBS. Other eligibility requirements or exclusions may apply. Mesalazine is a common, established treatment for inflammatory bowel disease …
Being Voices and Faces for Irritable Bowel Syndrome (IBS)
Some relatively recent followers of IBS Impact may not be aware that our main website includes an entire section devoted to IBS awareness or support for family members and friends of those with IBS. The section includes several articles, as well as the link to a University of North Carolina Center for Functional GI and Motility …
Online Survey From the IBS Network in the United Kingdom
This blog’s many readers in the United Kingdom may be interested in the following short, anonymous online survey from the IBS Network. The IBS Network, formerly known as The Gut Trust, is located in Sheffield and is the U.K.’s national organization for those with irritable bowel syndrome. The seven question survey addresses respondents’ experiences with …
IBS Impact’s Top 10 Posts of 2012
This blog was begun in July 2011, a few months after the launch of the main IBS Impact website, and a bit over a year after the inception of IBS Impact itself. It is intended as a supplement to the many resources on our main site, one that can be updated relatively quickly with time-sensitive news, advocacy …
IBS IMPACT 